FDA Approves ColoSense™ Colorectal Cancer Screening Test

May 14, 2024
|By Geneoscopy

FDA Approves ColoSense™ – Geneoscopy’s Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test